Alexion Pharmaceuticals stock rebounded from earlier premarket losses Friday despite a patent decision from European officials that could lead to a Soliris knockoff as early as 2021.

source https://finance.yahoo.com/m/9584d7b2-b2a4-310f-b9ec-6441ac33ee99/bad-news-keeps-piling-up-for.html?.tsrc=rss